nodes	percent_of_prediction	percent_of_DWPC	metapath
Toremifene—ESR1—osteoporosis	0.345	1	CbGaD
Toremifene—ESR1—Estropipate—osteoporosis	0.104	0.208	CbGbCtD
Toremifene—ESR1—Raloxifene—osteoporosis	0.0697	0.139	CbGbCtD
Toremifene—ESR1—Ethinyl Estradiol—osteoporosis	0.0673	0.134	CbGbCtD
Toremifene—ESR1—Conjugated Estrogens—osteoporosis	0.0494	0.0984	CbGbCtD
Toremifene—ESR1—Estradiol—osteoporosis	0.0434	0.0864	CbGbCtD
Toremifene—CYP1A1—Cholecalciferol—osteoporosis	0.0236	0.047	CbGbCtD
Toremifene—CYP1A2—Estropipate—osteoporosis	0.0205	0.0408	CbGbCtD
Toremifene—CYP1A1—Estradiol—osteoporosis	0.019	0.0379	CbGbCtD
Toremifene—ABCB1—Ethinyl Estradiol—osteoporosis	0.0115	0.023	CbGbCtD
Toremifene—CYP3A4—Estropipate—osteoporosis	0.0107	0.0214	CbGbCtD
Toremifene—CYP3A4—Calcitriol—osteoporosis	0.0107	0.0214	CbGbCtD
Toremifene—CYP1A2—Conjugated Estrogens—osteoporosis	0.00969	0.0193	CbGbCtD
Toremifene—CYP3A4—Ergocalciferol—osteoporosis	0.00858	0.0171	CbGbCtD
Toremifene—CYP1A2—Estradiol—osteoporosis	0.0085	0.0169	CbGbCtD
Toremifene—ABCB1—Conjugated Estrogens—osteoporosis	0.00847	0.0169	CbGbCtD
Toremifene—ABCB1—Estradiol—osteoporosis	0.00744	0.0148	CbGbCtD
Toremifene—CYP3A4—Raloxifene—osteoporosis	0.00716	0.0143	CbGbCtD
Toremifene—CYP3A4—Ethinyl Estradiol—osteoporosis	0.00691	0.0138	CbGbCtD
Toremifene—CYP3A4—Cholecalciferol—osteoporosis	0.00553	0.011	CbGbCtD
Toremifene—CYP3A4—Conjugated Estrogens—osteoporosis	0.00507	0.0101	CbGbCtD
Toremifene—CYP3A4—Estradiol—osteoporosis	0.00446	0.00887	CbGbCtD
Toremifene—Loperamide—POMC—osteoporosis	0.000761	0.305	CrCbGaD
Toremifene—Ospemifene—ESR1—osteoporosis	0.000471	0.189	CrCbGaD
Toremifene—Clomifene—CYP19A1—osteoporosis	0.000361	0.145	CrCbGaD
Toremifene—Clomifene—ESR1—osteoporosis	0.000332	0.133	CrCbGaD
Toremifene—Tamoxifen—ESR2—osteoporosis	0.000249	0.0998	CrCbGaD
Toremifene—Nervous system disorder—Estropipate—osteoporosis	0.000188	0.00132	CcSEcCtD
Toremifene—Hepatobiliary disease—Conjugated Estrogens—osteoporosis	0.000188	0.00132	CcSEcCtD
Toremifene—Chest pain—Calcitriol—osteoporosis	0.000188	0.00132	CcSEcCtD
Toremifene—Mental disorder—Risedronate—osteoporosis	0.000187	0.00131	CcSEcCtD
Toremifene—Breast disorder—Estradiol—osteoporosis	0.000186	0.00131	CcSEcCtD
Toremifene—Skin disorder—Estropipate—osteoporosis	0.000186	0.00131	CcSEcCtD
Toremifene—Malnutrition—Risedronate—osteoporosis	0.000185	0.0013	CcSEcCtD
Toremifene—Back pain—Ethinyl Estradiol—osteoporosis	0.000184	0.00129	CcSEcCtD
Toremifene—Angiopathy—Pamidronate—osteoporosis	0.000184	0.00129	CcSEcCtD
Toremifene—Mediastinal disorder—Pamidronate—osteoporosis	0.000183	0.00128	CcSEcCtD
Toremifene—Nervous system disorder—Raloxifene—osteoporosis	0.000182	0.00128	CcSEcCtD
Toremifene—Chills—Pamidronate—osteoporosis	0.000182	0.00128	CcSEcCtD
Toremifene—Thrombocytopenia—Raloxifene—osteoporosis	0.000182	0.00128	CcSEcCtD
Toremifene—Skin disorder—Raloxifene—osteoporosis	0.00018	0.00127	CcSEcCtD
Toremifene—Nervous system disorder—Ibandronate—osteoporosis	0.00018	0.00127	CcSEcCtD
Toremifene—Back pain—Risedronate—osteoporosis	0.000179	0.00126	CcSEcCtD
Toremifene—Hyperhidrosis—Raloxifene—osteoporosis	0.000179	0.00126	CcSEcCtD
Toremifene—Alopecia—Pamidronate—osteoporosis	0.000179	0.00126	CcSEcCtD
Toremifene—Skin disorder—Ibandronate—osteoporosis	0.000178	0.00125	CcSEcCtD
Toremifene—Hyperhidrosis—Ibandronate—osteoporosis	0.000178	0.00125	CcSEcCtD
Toremifene—Nausea—Ergocalciferol—osteoporosis	0.000177	0.00124	CcSEcCtD
Toremifene—Malnutrition—Pamidronate—osteoporosis	0.000176	0.00124	CcSEcCtD
Toremifene—Skin disorder—Calcitriol—osteoporosis	0.000175	0.00123	CcSEcCtD
Toremifene—Insomnia—Estropipate—osteoporosis	0.000173	0.00122	CcSEcCtD
Toremifene—Eye disorder—Zoledronate—osteoporosis	0.000173	0.00122	CcSEcCtD
Toremifene—Visual impairment—Conjugated Estrogens—osteoporosis	0.000172	0.00121	CcSEcCtD
Toremifene—Anorexia—Calcitriol—osteoporosis	0.000171	0.0012	CcSEcCtD
Toremifene—Back pain—Pamidronate—osteoporosis	0.000171	0.0012	CcSEcCtD
Toremifene—Angiopathy—Zoledronate—osteoporosis	0.000168	0.00118	CcSEcCtD
Toremifene—Insomnia—Raloxifene—osteoporosis	0.000168	0.00118	CcSEcCtD
Toremifene—Mediastinal disorder—Zoledronate—osteoporosis	0.000167	0.00117	CcSEcCtD
Toremifene—Vertigo—Risedronate—osteoporosis	0.000167	0.00117	CcSEcCtD
Toremifene—Tamoxifen—CYP19A1—osteoporosis	0.000167	0.0668	CrCbGaD
Toremifene—Eye disorder—Conjugated Estrogens—osteoporosis	0.000166	0.00117	CcSEcCtD
Toremifene—Insomnia—Ibandronate—osteoporosis	0.000166	0.00117	CcSEcCtD
Toremifene—Chills—Zoledronate—osteoporosis	0.000166	0.00117	CcSEcCtD
Toremifene—Gastrointestinal disorder—Estropipate—osteoporosis	0.000165	0.00116	CcSEcCtD
Toremifene—Arrhythmia—Zoledronate—osteoporosis	0.000165	0.00116	CcSEcCtD
Toremifene—Fatigue—Estropipate—osteoporosis	0.000165	0.00116	CcSEcCtD
Toremifene—Constipation—Estropipate—osteoporosis	0.000164	0.00115	CcSEcCtD
Toremifene—Pain—Estropipate—osteoporosis	0.000164	0.00115	CcSEcCtD
Toremifene—Alopecia—Zoledronate—osteoporosis	0.000164	0.00115	CcSEcCtD
Toremifene—Insomnia—Calcitriol—osteoporosis	0.000163	0.00114	CcSEcCtD
Toremifene—Weight increased—Estradiol—osteoporosis	0.000162	0.00114	CcSEcCtD
Toremifene—Mental disorder—Zoledronate—osteoporosis	0.000162	0.00114	CcSEcCtD
Toremifene—Angiopathy—Conjugated Estrogens—osteoporosis	0.000162	0.00114	CcSEcCtD
Toremifene—Pain—Alendronate—osteoporosis	0.000161	0.00113	CcSEcCtD
Toremifene—Constipation—Alendronate—osteoporosis	0.000161	0.00113	CcSEcCtD
Toremifene—Malnutrition—Zoledronate—osteoporosis	0.000161	0.00113	CcSEcCtD
Toremifene—Unspecified disorder of skin and subcutaneous tissue—Ethinyl Estradiol—osteoporosis	0.000161	0.00113	CcSEcCtD
Toremifene—Mediastinal disorder—Conjugated Estrogens—osteoporosis	0.000161	0.00113	CcSEcCtD
Toremifene—Gastrointestinal disorder—Raloxifene—osteoporosis	0.00016	0.00113	CcSEcCtD
Toremifene—Decreased appetite—Ibandronate—osteoporosis	0.00016	0.00112	CcSEcCtD
Toremifene—Arrhythmia—Conjugated Estrogens—osteoporosis	0.000159	0.00112	CcSEcCtD
Toremifene—Pain—Raloxifene—osteoporosis	0.000159	0.00112	CcSEcCtD
Toremifene—Gastrointestinal disorder—Ibandronate—osteoporosis	0.000159	0.00111	CcSEcCtD
Toremifene—Fatigue—Ibandronate—osteoporosis	0.000158	0.00111	CcSEcCtD
Toremifene—Chest pain—Risedronate—osteoporosis	0.000158	0.00111	CcSEcCtD
Toremifene—Leukopenia—Pamidronate—osteoporosis	0.000158	0.00111	CcSEcCtD
Toremifene—Alopecia—Conjugated Estrogens—osteoporosis	0.000157	0.00111	CcSEcCtD
Toremifene—Constipation—Ibandronate—osteoporosis	0.000157	0.0011	CcSEcCtD
Toremifene—Pain—Ibandronate—osteoporosis	0.000157	0.0011	CcSEcCtD
Toremifene—Unspecified disorder of skin and subcutaneous tissue—Risedronate—osteoporosis	0.000157	0.0011	CcSEcCtD
Toremifene—Pruritus—Etidronic acid—osteoporosis	0.000157	0.0011	CcSEcCtD
Toremifene—Acute coronary syndrome—Estradiol—osteoporosis	0.000157	0.0011	CcSEcCtD
Toremifene—Decreased appetite—Calcitriol—osteoporosis	0.000156	0.0011	CcSEcCtD
Toremifene—Mental disorder—Conjugated Estrogens—osteoporosis	0.000156	0.0011	CcSEcCtD
Toremifene—Back pain—Zoledronate—osteoporosis	0.000156	0.0011	CcSEcCtD
Toremifene—Myocardial infarction—Estradiol—osteoporosis	0.000156	0.00109	CcSEcCtD
Toremifene—Neuropathy peripheral—Estradiol—osteoporosis	0.000156	0.00109	CcSEcCtD
Toremifene—Oedema—Ethinyl Estradiol—osteoporosis	0.000155	0.00109	CcSEcCtD
Toremifene—Malnutrition—Conjugated Estrogens—osteoporosis	0.000155	0.00109	CcSEcCtD
Toremifene—Jaundice—Estradiol—osteoporosis	0.000155	0.00109	CcSEcCtD
Toremifene—Pain—Calcitriol—osteoporosis	0.000154	0.00108	CcSEcCtD
Toremifene—Constipation—Calcitriol—osteoporosis	0.000154	0.00108	CcSEcCtD
Toremifene—Tamoxifen—ESR1—osteoporosis	0.000153	0.0615	CrCbGaD
Toremifene—Nervous system disorder—Ethinyl Estradiol—osteoporosis	0.000152	0.00107	CcSEcCtD
Toremifene—Vision blurred—Zoledronate—osteoporosis	0.000152	0.00107	CcSEcCtD
Toremifene—Tremor—Zoledronate—osteoporosis	0.000151	0.00106	CcSEcCtD
Toremifene—Skin disorder—Ethinyl Estradiol—osteoporosis	0.000151	0.00106	CcSEcCtD
Toremifene—Hepatobiliary disease—Estradiol—osteoporosis	0.00015	0.00106	CcSEcCtD
Toremifene—Back pain—Conjugated Estrogens—osteoporosis	0.00015	0.00105	CcSEcCtD
Toremifene—Nervous system disorder—Risedronate—osteoporosis	0.000148	0.00104	CcSEcCtD
Toremifene—Skin disorder—Risedronate—osteoporosis	0.000147	0.00103	CcSEcCtD
Toremifene—Vision blurred—Conjugated Estrogens—osteoporosis	0.000146	0.00103	CcSEcCtD
Toremifene—Vertigo—Zoledronate—osteoporosis	0.000145	0.00102	CcSEcCtD
Toremifene—Leukopenia—Zoledronate—osteoporosis	0.000144	0.00101	CcSEcCtD
Toremifene—Oedema—Pamidronate—osteoporosis	0.000144	0.00101	CcSEcCtD
Toremifene—Nervous system disorder—Pamidronate—osteoporosis	0.000141	0.000992	CcSEcCtD
Toremifene—Thrombocytopenia—Pamidronate—osteoporosis	0.000141	0.00099	CcSEcCtD
Toremifene—Vomiting—Etidronic acid—osteoporosis	0.000141	0.00099	CcSEcCtD
Toremifene—Rash—Etidronic acid—osteoporosis	0.00014	0.000981	CcSEcCtD
Toremifene—Dermatitis—Etidronic acid—osteoporosis	0.000139	0.00098	CcSEcCtD
Toremifene—Vertigo—Conjugated Estrogens—osteoporosis	0.000139	0.000979	CcSEcCtD
Toremifene—Hyperhidrosis—Pamidronate—osteoporosis	0.000139	0.000978	CcSEcCtD
Toremifene—Headache—Etidronic acid—osteoporosis	0.000139	0.000975	CcSEcCtD
Toremifene—Asthenia—Estropipate—osteoporosis	0.000137	0.000966	CcSEcCtD
Toremifene—Visual impairment—Estradiol—osteoporosis	0.000137	0.000966	CcSEcCtD
Toremifene—Anorexia—Pamidronate—osteoporosis	0.000137	0.000964	CcSEcCtD
Toremifene—Chest pain—Zoledronate—osteoporosis	0.000137	0.000964	CcSEcCtD
Toremifene—Insomnia—Risedronate—osteoporosis	0.000137	0.000962	CcSEcCtD
Toremifene—Unspecified disorder of skin and subcutaneous tissue—Zoledronate—osteoporosis	0.000136	0.000957	CcSEcCtD
Toremifene—Pruritus—Estropipate—osteoporosis	0.000136	0.000953	CcSEcCtD
Toremifene—Asthenia—Alendronate—osteoporosis	0.000135	0.000951	CcSEcCtD
Toremifene—Dyspnoea—Risedronate—osteoporosis	0.000135	0.000949	CcSEcCtD
Toremifene—Gastrointestinal disorder—Ethinyl Estradiol—osteoporosis	0.000134	0.000942	CcSEcCtD
Toremifene—Fatigue—Ethinyl Estradiol—osteoporosis	0.000134	0.000941	CcSEcCtD
Toremifene—Pruritus—Alendronate—osteoporosis	0.000133	0.000938	CcSEcCtD
Toremifene—Eye disorder—Estradiol—osteoporosis	0.000133	0.000937	CcSEcCtD
Toremifene—Constipation—Ethinyl Estradiol—osteoporosis	0.000133	0.000933	CcSEcCtD
Toremifene—Chest pain—Conjugated Estrogens—osteoporosis	0.000132	0.000928	CcSEcCtD
Toremifene—Asthenia—Ibandronate—osteoporosis	0.000132	0.000926	CcSEcCtD
Toremifene—Nausea—Etidronic acid—osteoporosis	0.000132	0.000924	CcSEcCtD
Toremifene—Oedema—Zoledronate—osteoporosis	0.000131	0.000924	CcSEcCtD
Toremifene—Unspecified disorder of skin and subcutaneous tissue—Conjugated Estrogens—osteoporosis	0.000131	0.000922	CcSEcCtD
Toremifene—Gastrointestinal disorder—Risedronate—osteoporosis	0.000131	0.000919	CcSEcCtD
Toremifene—Fatigue—Risedronate—osteoporosis	0.000131	0.000917	CcSEcCtD
Toremifene—Insomnia—Pamidronate—osteoporosis	0.00013	0.000915	CcSEcCtD
Toremifene—Pruritus—Ibandronate—osteoporosis	0.00013	0.000913	CcSEcCtD
Toremifene—Pain—Risedronate—osteoporosis	0.000129	0.00091	CcSEcCtD
Toremifene—Constipation—Risedronate—osteoporosis	0.000129	0.00091	CcSEcCtD
Toremifene—Angiopathy—Estradiol—osteoporosis	0.000129	0.000909	CcSEcCtD
Toremifene—Asthenia—Calcitriol—osteoporosis	0.000129	0.000907	CcSEcCtD
Toremifene—Nervous system disorder—Zoledronate—osteoporosis	0.000129	0.000906	CcSEcCtD
Toremifene—Thrombocytopenia—Zoledronate—osteoporosis	0.000129	0.000905	CcSEcCtD
Toremifene—Mediastinal disorder—Estradiol—osteoporosis	0.000129	0.000903	CcSEcCtD
Toremifene—Dyspnoea—Pamidronate—osteoporosis	0.000128	0.000902	CcSEcCtD
Toremifene—Chills—Estradiol—osteoporosis	0.000128	0.000899	CcSEcCtD
Toremifene—Skin disorder—Zoledronate—osteoporosis	0.000128	0.000897	CcSEcCtD
Toremifene—Pruritus—Calcitriol—osteoporosis	0.000127	0.000894	CcSEcCtD
Toremifene—Hyperhidrosis—Zoledronate—osteoporosis	0.000127	0.000893	CcSEcCtD
Toremifene—Dizziness—Estropipate—osteoporosis	0.000127	0.00089	CcSEcCtD
Toremifene—Oedema—Conjugated Estrogens—osteoporosis	0.000127	0.00089	CcSEcCtD
Toremifene—Alopecia—Estradiol—osteoporosis	0.000126	0.000886	CcSEcCtD
Toremifene—Anorexia—Zoledronate—osteoporosis	0.000125	0.000881	CcSEcCtD
Toremifene—Decreased appetite—Pamidronate—osteoporosis	0.000125	0.000879	CcSEcCtD
Toremifene—Mental disorder—Estradiol—osteoporosis	0.000125	0.000878	CcSEcCtD
Toremifene—Dizziness—Alendronate—osteoporosis	0.000125	0.000877	CcSEcCtD
Toremifene—Gastrointestinal disorder—Pamidronate—osteoporosis	0.000124	0.000873	CcSEcCtD
Toremifene—Nervous system disorder—Conjugated Estrogens—osteoporosis	0.000124	0.000872	CcSEcCtD
Toremifene—Malnutrition—Estradiol—osteoporosis	0.000124	0.000872	CcSEcCtD
Toremifene—Fatigue—Pamidronate—osteoporosis	0.000124	0.000872	CcSEcCtD
Toremifene—Constipation—Pamidronate—osteoporosis	0.000123	0.000865	CcSEcCtD
Toremifene—Pain—Pamidronate—osteoporosis	0.000123	0.000865	CcSEcCtD
Toremifene—Skin disorder—Conjugated Estrogens—osteoporosis	0.000123	0.000864	CcSEcCtD
Toremifene—Dizziness—Raloxifene—osteoporosis	0.000123	0.000862	CcSEcCtD
Toremifene—Hyperhidrosis—Conjugated Estrogens—osteoporosis	0.000122	0.00086	CcSEcCtD
Toremifene—Vomiting—Estropipate—osteoporosis	0.000122	0.000856	CcSEcCtD
Toremifene—Dizziness—Ibandronate—osteoporosis	0.000121	0.000854	CcSEcCtD
Toremifene—Rash—Estropipate—osteoporosis	0.000121	0.000849	CcSEcCtD
Toremifene—Dermatitis—Estropipate—osteoporosis	0.000121	0.000848	CcSEcCtD
Toremifene—Anorexia—Conjugated Estrogens—osteoporosis	0.000121	0.000848	CcSEcCtD
Toremifene—Back pain—Estradiol—osteoporosis	0.00012	0.000844	CcSEcCtD
Toremifene—Headache—Estropipate—osteoporosis	0.00012	0.000843	CcSEcCtD
Toremifene—Vomiting—Alendronate—osteoporosis	0.00012	0.000843	CcSEcCtD
Toremifene—Rash—Alendronate—osteoporosis	0.000119	0.000836	CcSEcCtD
Toremifene—Insomnia—Zoledronate—osteoporosis	0.000119	0.000836	CcSEcCtD
Toremifene—Dermatitis—Alendronate—osteoporosis	0.000119	0.000835	CcSEcCtD
Toremifene—Headache—Alendronate—osteoporosis	0.000118	0.000831	CcSEcCtD
Toremifene—Vomiting—Raloxifene—osteoporosis	0.000118	0.000829	CcSEcCtD
Toremifene—Dyspnoea—Zoledronate—osteoporosis	0.000117	0.000824	CcSEcCtD
Toremifene—Rash—Raloxifene—osteoporosis	0.000117	0.000822	CcSEcCtD
Toremifene—Dermatitis—Raloxifene—osteoporosis	0.000117	0.000822	CcSEcCtD
Toremifene—Vomiting—Ibandronate—osteoporosis	0.000117	0.000821	CcSEcCtD
Toremifene—Tremor—Estradiol—osteoporosis	0.000116	0.000817	CcSEcCtD
Toremifene—Headache—Raloxifene—osteoporosis	0.000116	0.000817	CcSEcCtD
Toremifene—Rash—Ibandronate—osteoporosis	0.000116	0.000814	CcSEcCtD
Toremifene—Dermatitis—Ibandronate—osteoporosis	0.000116	0.000813	CcSEcCtD
Toremifene—Headache—Ibandronate—osteoporosis	0.000115	0.000809	CcSEcCtD
Toremifene—Insomnia—Conjugated Estrogens—osteoporosis	0.000114	0.000805	CcSEcCtD
Toremifene—Vomiting—Calcitriol—osteoporosis	0.000114	0.000804	CcSEcCtD
Toremifene—Decreased appetite—Zoledronate—osteoporosis	0.000114	0.000803	CcSEcCtD
Toremifene—Nausea—Estropipate—osteoporosis	0.000114	0.0008	CcSEcCtD
Toremifene—Gastrointestinal disorder—Zoledronate—osteoporosis	0.000113	0.000798	CcSEcCtD
Toremifene—Rash—Calcitriol—osteoporosis	0.000113	0.000797	CcSEcCtD
Toremifene—Fatigue—Zoledronate—osteoporosis	0.000113	0.000797	CcSEcCtD
Toremifene—Dermatitis—Calcitriol—osteoporosis	0.000113	0.000796	CcSEcCtD
Toremifene—Dyspnoea—Conjugated Estrogens—osteoporosis	0.000113	0.000793	CcSEcCtD
Toremifene—Headache—Calcitriol—osteoporosis	0.000113	0.000792	CcSEcCtD
Toremifene—Constipation—Zoledronate—osteoporosis	0.000112	0.00079	CcSEcCtD
Toremifene—Pain—Zoledronate—osteoporosis	0.000112	0.00079	CcSEcCtD
Toremifene—Nausea—Alendronate—osteoporosis	0.000112	0.000788	CcSEcCtD
Toremifene—Vertigo—Estradiol—osteoporosis	0.000112	0.000784	CcSEcCtD
Toremifene—Asthenia—Ethinyl Estradiol—osteoporosis	0.000111	0.000783	CcSEcCtD
Toremifene—Nausea—Raloxifene—osteoporosis	0.00011	0.000775	CcSEcCtD
Toremifene—Decreased appetite—Conjugated Estrogens—osteoporosis	0.00011	0.000773	CcSEcCtD
Toremifene—Pruritus—Ethinyl Estradiol—osteoporosis	0.00011	0.000772	CcSEcCtD
Toremifene—Gastrointestinal disorder—Conjugated Estrogens—osteoporosis	0.000109	0.000768	CcSEcCtD
Toremifene—Fatigue—Conjugated Estrogens—osteoporosis	0.000109	0.000767	CcSEcCtD
Toremifene—Nausea—Ibandronate—osteoporosis	0.000109	0.000767	CcSEcCtD
Toremifene—Asthenia—Risedronate—osteoporosis	0.000109	0.000763	CcSEcCtD
Toremifene—Pain—Conjugated Estrogens—osteoporosis	0.000108	0.000761	CcSEcCtD
Toremifene—Constipation—Conjugated Estrogens—osteoporosis	0.000108	0.000761	CcSEcCtD
Toremifene—Pruritus—Risedronate—osteoporosis	0.000107	0.000753	CcSEcCtD
Toremifene—Nausea—Calcitriol—osteoporosis	0.000107	0.000751	CcSEcCtD
Toremifene—Chest pain—Estradiol—osteoporosis	0.000106	0.000743	CcSEcCtD
Toremifene—Unspecified disorder of skin and subcutaneous tissue—Estradiol—osteoporosis	0.000105	0.000738	CcSEcCtD
Toremifene—Asthenia—Pamidronate—osteoporosis	0.000103	0.000726	CcSEcCtD
Toremifene—Dizziness—Ethinyl Estradiol—osteoporosis	0.000103	0.000722	CcSEcCtD
Toremifene—Pruritus—Pamidronate—osteoporosis	0.000102	0.000716	CcSEcCtD
Toremifene—Oedema—Estradiol—osteoporosis	0.000101	0.000712	CcSEcCtD
Toremifene—Dizziness—Risedronate—osteoporosis	0.0001	0.000704	CcSEcCtD
Toremifene—Nervous system disorder—Estradiol—osteoporosis	9.93e-05	0.000698	CcSEcCtD
Toremifene—Vomiting—Ethinyl Estradiol—osteoporosis	9.87e-05	0.000694	CcSEcCtD
Toremifene—Skin disorder—Estradiol—osteoporosis	9.84e-05	0.000692	CcSEcCtD
Toremifene—Hyperhidrosis—Estradiol—osteoporosis	9.79e-05	0.000688	CcSEcCtD
Toremifene—Rash—Ethinyl Estradiol—osteoporosis	9.79e-05	0.000688	CcSEcCtD
Toremifene—Dermatitis—Ethinyl Estradiol—osteoporosis	9.78e-05	0.000687	CcSEcCtD
Toremifene—Headache—Ethinyl Estradiol—osteoporosis	9.73e-05	0.000684	CcSEcCtD
Toremifene—Vomiting—Risedronate—osteoporosis	9.63e-05	0.000677	CcSEcCtD
Toremifene—Rash—Risedronate—osteoporosis	9.55e-05	0.000671	CcSEcCtD
Toremifene—Dermatitis—Risedronate—osteoporosis	9.54e-05	0.00067	CcSEcCtD
Toremifene—Dizziness—Pamidronate—osteoporosis	9.52e-05	0.000669	CcSEcCtD
Toremifene—Headache—Risedronate—osteoporosis	9.48e-05	0.000667	CcSEcCtD
Toremifene—Asthenia—Zoledronate—osteoporosis	9.43e-05	0.000663	CcSEcCtD
Toremifene—Pruritus—Zoledronate—osteoporosis	9.3e-05	0.000654	CcSEcCtD
Toremifene—Nausea—Ethinyl Estradiol—osteoporosis	9.22e-05	0.000648	CcSEcCtD
Toremifene—Insomnia—Estradiol—osteoporosis	9.16e-05	0.000644	CcSEcCtD
Toremifene—Vomiting—Pamidronate—osteoporosis	9.15e-05	0.000643	CcSEcCtD
Toremifene—Asthenia—Conjugated Estrogens—osteoporosis	9.08e-05	0.000638	CcSEcCtD
Toremifene—Rash—Pamidronate—osteoporosis	9.07e-05	0.000638	CcSEcCtD
Toremifene—Dermatitis—Pamidronate—osteoporosis	9.07e-05	0.000637	CcSEcCtD
Toremifene—Dyspnoea—Estradiol—osteoporosis	9.03e-05	0.000635	CcSEcCtD
Toremifene—Headache—Pamidronate—osteoporosis	9.02e-05	0.000634	CcSEcCtD
Toremifene—Nausea—Risedronate—osteoporosis	8.99e-05	0.000632	CcSEcCtD
Toremifene—Pruritus—Conjugated Estrogens—osteoporosis	8.96e-05	0.000629	CcSEcCtD
Toremifene—Decreased appetite—Estradiol—osteoporosis	8.81e-05	0.000619	CcSEcCtD
Toremifene—Gastrointestinal disorder—Estradiol—osteoporosis	8.75e-05	0.000615	CcSEcCtD
Toremifene—Fatigue—Estradiol—osteoporosis	8.73e-05	0.000614	CcSEcCtD
Toremifene—Dizziness—Zoledronate—osteoporosis	8.69e-05	0.000611	CcSEcCtD
Toremifene—Constipation—Estradiol—osteoporosis	8.66e-05	0.000609	CcSEcCtD
Toremifene—Pain—Estradiol—osteoporosis	8.66e-05	0.000609	CcSEcCtD
Toremifene—Nausea—Pamidronate—osteoporosis	8.55e-05	0.000601	CcSEcCtD
Toremifene—Dizziness—Conjugated Estrogens—osteoporosis	8.37e-05	0.000588	CcSEcCtD
Toremifene—Vomiting—Zoledronate—osteoporosis	8.36e-05	0.000587	CcSEcCtD
Toremifene—Rash—Zoledronate—osteoporosis	8.29e-05	0.000583	CcSEcCtD
Toremifene—Dermatitis—Zoledronate—osteoporosis	8.28e-05	0.000582	CcSEcCtD
Toremifene—Headache—Zoledronate—osteoporosis	8.24e-05	0.000579	CcSEcCtD
Toremifene—Vomiting—Conjugated Estrogens—osteoporosis	8.05e-05	0.000566	CcSEcCtD
Toremifene—Rash—Conjugated Estrogens—osteoporosis	7.98e-05	0.000561	CcSEcCtD
Toremifene—Dermatitis—Conjugated Estrogens—osteoporosis	7.97e-05	0.00056	CcSEcCtD
Toremifene—Headache—Conjugated Estrogens—osteoporosis	7.93e-05	0.000557	CcSEcCtD
Toremifene—Nausea—Zoledronate—osteoporosis	7.81e-05	0.000549	CcSEcCtD
Toremifene—Nausea—Conjugated Estrogens—osteoporosis	7.52e-05	0.000528	CcSEcCtD
Toremifene—Asthenia—Estradiol—osteoporosis	7.27e-05	0.000511	CcSEcCtD
Toremifene—Pruritus—Estradiol—osteoporosis	7.17e-05	0.000504	CcSEcCtD
Toremifene—Dizziness—Estradiol—osteoporosis	6.7e-05	0.000471	CcSEcCtD
Toremifene—Vomiting—Estradiol—osteoporosis	6.44e-05	0.000453	CcSEcCtD
Toremifene—Rash—Estradiol—osteoporosis	6.39e-05	0.000449	CcSEcCtD
Toremifene—Dermatitis—Estradiol—osteoporosis	6.38e-05	0.000449	CcSEcCtD
Toremifene—Headache—Estradiol—osteoporosis	6.35e-05	0.000446	CcSEcCtD
Toremifene—Nausea—Estradiol—osteoporosis	6.02e-05	0.000423	CcSEcCtD
Toremifene—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP27A1—osteoporosis	5.54e-05	0.00667	CbGpPWpGaD
Toremifene—ABCB1—HIF-1-alpha transcription factor network—ENO1—osteoporosis	5.47e-05	0.0066	CbGpPWpGaD
Toremifene—ESR1—Integrated Pancreatic Cancer Pathway—RAP1A—osteoporosis	5.47e-05	0.00659	CbGpPWpGaD
Toremifene—CYP3A4—Oxidation by Cytochrome P450—CYP27A1—osteoporosis	5.46e-05	0.00659	CbGpPWpGaD
Toremifene—ESR1—Leptin signaling pathway—LEP—osteoporosis	5.22e-05	0.00629	CbGpPWpGaD
Toremifene—CYP3A4—Farnesoid X Receptor  Pathway—IRS2—osteoporosis	5.22e-05	0.00629	CbGpPWpGaD
Toremifene—CYP1A2—Nuclear Receptors in Lipid Metabolism and Toxicity—VDR—osteoporosis	5.19e-05	0.00626	CbGpPWpGaD
Toremifene—CYP1A1—Aryl Hydrocarbon Receptor—ESR1—osteoporosis	4.88e-05	0.00589	CbGpPWpGaD
Toremifene—CYP1A1—Biological oxidations—CYP27A1—osteoporosis	4.84e-05	0.00584	CbGpPWpGaD
Toremifene—CYP1A1—Phase 1 - Functionalization of compounds—CYP19A1—osteoporosis	4.79e-05	0.00578	CbGpPWpGaD
Toremifene—CYP1A1—Metapathway biotransformation—CYP27A1—osteoporosis	4.78e-05	0.00576	CbGpPWpGaD
Toremifene—CYP1A2—Tryptophan metabolism—CYP19A1—osteoporosis	4.66e-05	0.00562	CbGpPWpGaD
Toremifene—ESR1—Leptin signaling pathway—IRS1—osteoporosis	4.66e-05	0.00562	CbGpPWpGaD
Toremifene—CYP3A4—Phase 1 - Functionalization of compounds—CYP27A1—osteoporosis	4.49e-05	0.00541	CbGpPWpGaD
Toremifene—ESR1—Signaling by ERBB4—KL—osteoporosis	4.42e-05	0.00533	CbGpPWpGaD
Toremifene—ESR1—Integrated Breast Cancer Pathway—CYP19A1—osteoporosis	4.26e-05	0.00514	CbGpPWpGaD
Toremifene—ESR1—FOXM1 transcription factor network—MYC—osteoporosis	4.12e-05	0.00497	CbGpPWpGaD
Toremifene—ESR1—LKB1 signaling events—MYC—osteoporosis	4.05e-05	0.00488	CbGpPWpGaD
Toremifene—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—VDR—osteoporosis	4e-05	0.00483	CbGpPWpGaD
Toremifene—ESR1—Integrated Pancreatic Cancer Pathway—ESR2—osteoporosis	3.89e-05	0.00469	CbGpPWpGaD
Toremifene—ESR1—Aryl Hydrocarbon Receptor—MYC—osteoporosis	3.83e-05	0.00462	CbGpPWpGaD
Toremifene—CYP1A2—Cytochrome P450 - arranged by substrate type—CYP19A1—osteoporosis	3.77e-05	0.00454	CbGpPWpGaD
Toremifene—CYP1A2—Oxidation by Cytochrome P450—CYP19A1—osteoporosis	3.72e-05	0.00448	CbGpPWpGaD
Toremifene—CYP3A4—Tryptophan metabolism—CYP19A1—osteoporosis	3.6e-05	0.00434	CbGpPWpGaD
Toremifene—ESR1—Aryl Hydrocarbon Receptor—TNF—osteoporosis	3.57e-05	0.00431	CbGpPWpGaD
Toremifene—CYP1A1—Cytochrome P450 - arranged by substrate type—POMC—osteoporosis	3.55e-05	0.00428	CbGpPWpGaD
Toremifene—CYP1A2—Arachidonic acid metabolism—GPX1—osteoporosis	3.55e-05	0.00428	CbGpPWpGaD
Toremifene—ESR1—Leptin signaling pathway—IL1B—osteoporosis	3.33e-05	0.00401	CbGpPWpGaD
Toremifene—CYP1A1—Aryl Hydrocarbon Receptor Pathway—IL1B—osteoporosis	3.26e-05	0.00393	CbGpPWpGaD
Toremifene—CYP1A1—Metabolism of lipids and lipoproteins—FDPS—osteoporosis	3.24e-05	0.00391	CbGpPWpGaD
Toremifene—CYP1A2—Aryl Hydrocarbon Receptor—ESR1—osteoporosis	3.11e-05	0.00375	CbGpPWpGaD
Toremifene—CYP1A2—Biological oxidations—CYP27A1—osteoporosis	3.09e-05	0.00372	CbGpPWpGaD
Toremifene—CYP1A1—Metabolism of lipids and lipoproteins—GPD2—osteoporosis	3.07e-05	0.0037	CbGpPWpGaD
Toremifene—ABCB1—HIF-1-alpha transcription factor network—LEP—osteoporosis	3.06e-05	0.00369	CbGpPWpGaD
Toremifene—CYP1A2—Phase 1 - Functionalization of compounds—CYP19A1—osteoporosis	3.05e-05	0.00368	CbGpPWpGaD
Toremifene—CYP1A2—Metapathway biotransformation—CYP27A1—osteoporosis	3.05e-05	0.00367	CbGpPWpGaD
Toremifene—ESR1—Signaling by ERBB4—IRS2—osteoporosis	3.03e-05	0.00366	CbGpPWpGaD
Toremifene—ESR1—Validated nuclear estrogen receptor alpha network—MYC—osteoporosis	2.94e-05	0.00355	CbGpPWpGaD
Toremifene—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP19A1—osteoporosis	2.91e-05	0.00351	CbGpPWpGaD
Toremifene—ABCB1—Integrated Pancreatic Cancer Pathway—RAP1A—osteoporosis	2.89e-05	0.00349	CbGpPWpGaD
Toremifene—CYP1A1—Phase 1 - Functionalization of compounds—POMC—osteoporosis	2.88e-05	0.00347	CbGpPWpGaD
Toremifene—CYP3A4—Oxidation by Cytochrome P450—CYP19A1—osteoporosis	2.87e-05	0.00346	CbGpPWpGaD
Toremifene—ESR1—Regulation of Telomerase—MYC—osteoporosis	2.8e-05	0.00338	CbGpPWpGaD
Toremifene—ESR1—Regulation of Telomerase—TGFB1—osteoporosis	2.8e-05	0.00337	CbGpPWpGaD
Toremifene—ESR1—AP-1 transcription factor network—MYC—osteoporosis	2.74e-05	0.0033	CbGpPWpGaD
Toremifene—ESR1—AP-1 transcription factor network—TGFB1—osteoporosis	2.73e-05	0.0033	CbGpPWpGaD
Toremifene—ESR1—Integrated Breast Cancer Pathway—IRS1—osteoporosis	2.66e-05	0.00321	CbGpPWpGaD
Toremifene—ESR1—Signaling by ERBB4—IRS1—osteoporosis	2.65e-05	0.00319	CbGpPWpGaD
Toremifene—CYP1A1—Biological oxidations—CYP19A1—osteoporosis	2.54e-05	0.00307	CbGpPWpGaD
Toremifene—CYP1A1—Aryl Hydrocarbon Receptor—MYC—osteoporosis	2.54e-05	0.00306	CbGpPWpGaD
Toremifene—CYP1A1—Aryl Hydrocarbon Receptor Pathway—TGFB1—osteoporosis	2.53e-05	0.00305	CbGpPWpGaD
Toremifene—CYP1A1—Metapathway biotransformation—CYP19A1—osteoporosis	2.51e-05	0.00303	CbGpPWpGaD
Toremifene—ESR1—Signaling by ERBB4—IL6R—osteoporosis	2.49e-05	0.003	CbGpPWpGaD
Toremifene—ESR1—Regulation of nuclear SMAD2/3 signaling—MYC—osteoporosis	2.44e-05	0.00294	CbGpPWpGaD
Toremifene—ESR1—Gene Expression—U2AF1—osteoporosis	2.43e-05	0.00293	CbGpPWpGaD
Toremifene—CYP1A1—Metabolism of lipids and lipoproteins—OXCT1—osteoporosis	2.39e-05	0.00288	CbGpPWpGaD
Toremifene—CYP3A4—Biological oxidations—CYP27A1—osteoporosis	2.38e-05	0.00287	CbGpPWpGaD
Toremifene—CYP1A1—Aryl Hydrocarbon Receptor Pathway—TNF—osteoporosis	2.37e-05	0.00285	CbGpPWpGaD
Toremifene—CYP1A1—Aryl Hydrocarbon Receptor—TNF—osteoporosis	2.37e-05	0.00285	CbGpPWpGaD
Toremifene—ESR1—ATF-2 transcription factor network—IL6—osteoporosis	2.36e-05	0.00285	CbGpPWpGaD
Toremifene—CYP3A4—Phase 1 - Functionalization of compounds—CYP19A1—osteoporosis	2.36e-05	0.00284	CbGpPWpGaD
Toremifene—CYP3A4—Metapathway biotransformation—CYP27A1—osteoporosis	2.35e-05	0.00283	CbGpPWpGaD
Toremifene—CYP1A1—Metabolism of lipids and lipoproteins—MGLL—osteoporosis	2.33e-05	0.00281	CbGpPWpGaD
Toremifene—CYP1A2—Cytochrome P450 - arranged by substrate type—POMC—osteoporosis	2.26e-05	0.00273	CbGpPWpGaD
Toremifene—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IL1B—osteoporosis	2.08e-05	0.00251	CbGpPWpGaD
Toremifene—CYP1A2—Metabolism of lipids and lipoproteins—FDPS—osteoporosis	2.07e-05	0.00249	CbGpPWpGaD
Toremifene—ESR1—AP-1 transcription factor network—IL6—osteoporosis	2.06e-05	0.00248	CbGpPWpGaD
Toremifene—ABCB1—Integrated Pancreatic Cancer Pathway—ESR2—osteoporosis	2.06e-05	0.00248	CbGpPWpGaD
Toremifene—ESR1—Integrated Pancreatic Cancer Pathway—IGF1—osteoporosis	2.04e-05	0.00246	CbGpPWpGaD
Toremifene—CYP1A2—Metabolism of lipids and lipoproteins—GPD2—osteoporosis	1.96e-05	0.00236	CbGpPWpGaD
Toremifene—ESR1—Generic Transcription Pathway—ESR2—osteoporosis	1.93e-05	0.00233	CbGpPWpGaD
Toremifene—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—MYC—osteoporosis	1.93e-05	0.00232	CbGpPWpGaD
Toremifene—CYP1A1—Metabolism of lipids and lipoproteins—CYP27A1—osteoporosis	1.86e-05	0.00224	CbGpPWpGaD
Toremifene—CYP1A2—Phase 1 - Functionalization of compounds—POMC—osteoporosis	1.84e-05	0.00221	CbGpPWpGaD
Toremifene—ESR1—Signaling Pathways—SOST—osteoporosis	1.82e-05	0.0022	CbGpPWpGaD
Toremifene—ESR1—Gene Expression—RPL24—osteoporosis	1.8e-05	0.00218	CbGpPWpGaD
Toremifene—CYP3A4—Cytochrome P450 - arranged by substrate type—POMC—osteoporosis	1.75e-05	0.00211	CbGpPWpGaD
Toremifene—ABCB1—Allograft Rejection—IL1B—osteoporosis	1.69e-05	0.00204	CbGpPWpGaD
Toremifene—ESR1—Signaling Pathways—PTH1R—osteoporosis	1.65e-05	0.00199	CbGpPWpGaD
Toremifene—ESR1—Signaling Pathways—CALCR—osteoporosis	1.65e-05	0.00199	CbGpPWpGaD
Toremifene—CYP1A2—Biological oxidations—CYP19A1—osteoporosis	1.62e-05	0.00196	CbGpPWpGaD
Toremifene—CYP1A2—Aryl Hydrocarbon Receptor—MYC—osteoporosis	1.62e-05	0.00195	CbGpPWpGaD
Toremifene—ABCB1—Transmembrane transport of small molecules—ANXA2—osteoporosis	1.62e-05	0.00195	CbGpPWpGaD
Toremifene—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TGFB1—osteoporosis	1.62e-05	0.00195	CbGpPWpGaD
Toremifene—CYP1A2—Metapathway biotransformation—CYP19A1—osteoporosis	1.6e-05	0.00193	CbGpPWpGaD
Toremifene—CYP1A1—Metabolism of lipids and lipoproteins—P4HB—osteoporosis	1.58e-05	0.00191	CbGpPWpGaD
Toremifene—ESR1—Generic Transcription Pathway—VDR—osteoporosis	1.53e-05	0.00185	CbGpPWpGaD
Toremifene—CYP1A1—Biological oxidations—POMC—osteoporosis	1.53e-05	0.00184	CbGpPWpGaD
Toremifene—CYP1A2—Metabolism of lipids and lipoproteins—OXCT1—osteoporosis	1.52e-05	0.00184	CbGpPWpGaD
Toremifene—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TNF—osteoporosis	1.51e-05	0.00182	CbGpPWpGaD
Toremifene—CYP1A2—Aryl Hydrocarbon Receptor—TNF—osteoporosis	1.51e-05	0.00182	CbGpPWpGaD
Toremifene—CYP1A2—Metabolism of lipids and lipoproteins—MGLL—osteoporosis	1.48e-05	0.00179	CbGpPWpGaD
Toremifene—ESR1—Integrated Breast Cancer Pathway—MYC—osteoporosis	1.48e-05	0.00179	CbGpPWpGaD
Toremifene—CYP1A1—Metabolism—PKM—osteoporosis	1.44e-05	0.00174	CbGpPWpGaD
Toremifene—CYP1A1—Metabolism—FDPS—osteoporosis	1.44e-05	0.00174	CbGpPWpGaD
Toremifene—CYP3A4—Phase 1 - Functionalization of compounds—POMC—osteoporosis	1.42e-05	0.00171	CbGpPWpGaD
Toremifene—CYP1A1—Metabolism—GPD2—osteoporosis	1.37e-05	0.00165	CbGpPWpGaD
Toremifene—CYP1A1—Metabolism—PGLS—osteoporosis	1.37e-05	0.00165	CbGpPWpGaD
Toremifene—ABCB1—Allograft Rejection—TGFB1—osteoporosis	1.31e-05	0.00158	CbGpPWpGaD
Toremifene—ESR1—Signaling Pathways—MGLL—osteoporosis	1.31e-05	0.00158	CbGpPWpGaD
Toremifene—ESR1—Signaling Pathways—LRP5—osteoporosis	1.28e-05	0.00154	CbGpPWpGaD
Toremifene—CYP3A4—Biological oxidations—CYP19A1—osteoporosis	1.25e-05	0.00151	CbGpPWpGaD
Toremifene—CYP1A1—Metabolism—ATIC—osteoporosis	1.25e-05	0.00151	CbGpPWpGaD
Toremifene—CYP1A1—Metabolism—PNP—osteoporosis	1.25e-05	0.00151	CbGpPWpGaD
Toremifene—ABCB1—Integrated Pancreatic Cancer Pathway—ESR1—osteoporosis	1.25e-05	0.00151	CbGpPWpGaD
Toremifene—CYP3A4—Metapathway biotransformation—CYP19A1—osteoporosis	1.24e-05	0.00149	CbGpPWpGaD
Toremifene—ESR1—Integrated Pancreatic Cancer Pathway—MYC—osteoporosis	1.23e-05	0.00148	CbGpPWpGaD
Toremifene—ABCB1—Allograft Rejection—TNF—osteoporosis	1.23e-05	0.00148	CbGpPWpGaD
Toremifene—ESR1—Integrated Pancreatic Cancer Pathway—TGFB1—osteoporosis	1.22e-05	0.00148	CbGpPWpGaD
Toremifene—ESR1—Signaling Pathways—LRP6—osteoporosis	1.22e-05	0.00147	CbGpPWpGaD
Toremifene—CYP1A2—Metabolism of lipids and lipoproteins—CYP27A1—osteoporosis	1.19e-05	0.00143	CbGpPWpGaD
Toremifene—ABCB1—Metabolism—PKM—osteoporosis	1.15e-05	0.00139	CbGpPWpGaD
Toremifene—ABCB1—Metabolism—FDPS—osteoporosis	1.15e-05	0.00139	CbGpPWpGaD
Toremifene—ESR1—Integrated Pancreatic Cancer Pathway—TNF—osteoporosis	1.14e-05	0.00138	CbGpPWpGaD
Toremifene—ESR1—Signaling by ERBB4—IL6—osteoporosis	1.11e-05	0.00134	CbGpPWpGaD
Toremifene—ABCB1—Metabolism—GPD2—osteoporosis	1.09e-05	0.00132	CbGpPWpGaD
Toremifene—ABCB1—Metabolism—PGLS—osteoporosis	1.09e-05	0.00132	CbGpPWpGaD
Toremifene—ABCB1—Integrated Pancreatic Cancer Pathway—IGF1—osteoporosis	1.08e-05	0.0013	CbGpPWpGaD
Toremifene—CYP1A1—Metabolism—CA2—osteoporosis	1.06e-05	0.00128	CbGpPWpGaD
Toremifene—CYP1A1—Metabolism—OXCT1—osteoporosis	1.06e-05	0.00128	CbGpPWpGaD
Toremifene—ESR1—Gene Expression—PSMA2—osteoporosis	1.04e-05	0.00126	CbGpPWpGaD
Toremifene—ESR1—Gene Expression—PSMA5—osteoporosis	1.04e-05	0.00126	CbGpPWpGaD
Toremifene—CYP1A1—Metabolism—MGLL—osteoporosis	1.04e-05	0.00125	CbGpPWpGaD
Toremifene—ESR1—Signaling Pathways—TLN1—osteoporosis	1.03e-05	0.00124	CbGpPWpGaD
Toremifene—CYP1A2—Metabolism of lipids and lipoproteins—P4HB—osteoporosis	1.01e-05	0.00122	CbGpPWpGaD
Toremifene—ABCB1—Metabolism—PNP—osteoporosis	9.99e-06	0.0012	CbGpPWpGaD
Toremifene—ABCB1—Metabolism—ATIC—osteoporosis	9.99e-06	0.0012	CbGpPWpGaD
Toremifene—CYP1A1—Metabolism of lipids and lipoproteins—CYP19A1—osteoporosis	9.77e-06	0.00118	CbGpPWpGaD
Toremifene—CYP1A2—Biological oxidations—POMC—osteoporosis	9.75e-06	0.00118	CbGpPWpGaD
Toremifene—ESR1—Gene Expression—ESR2—osteoporosis	9.3e-06	0.00112	CbGpPWpGaD
Toremifene—CYP1A2—Metabolism—PKM—osteoporosis	9.2e-06	0.00111	CbGpPWpGaD
Toremifene—CYP1A2—Metabolism—FDPS—osteoporosis	9.2e-06	0.00111	CbGpPWpGaD
Toremifene—ESR1—Signaling Pathways—P4HB—osteoporosis	8.89e-06	0.00107	CbGpPWpGaD
Toremifene—CYP1A1—Metabolism—IDH2—osteoporosis	8.81e-06	0.00106	CbGpPWpGaD
Toremifene—CYP1A2—Metabolism—PGLS—osteoporosis	8.72e-06	0.00105	CbGpPWpGaD
Toremifene—CYP1A2—Metabolism—GPD2—osteoporosis	8.72e-06	0.00105	CbGpPWpGaD
Toremifene—ESR1—Signaling Pathways—PTH—osteoporosis	8.65e-06	0.00104	CbGpPWpGaD
Toremifene—ESR1—Signaling Pathways—RAP1A—osteoporosis	8.5e-06	0.00102	CbGpPWpGaD
Toremifene—ABCB1—Metabolism—CA2—osteoporosis	8.49e-06	0.00102	CbGpPWpGaD
Toremifene—ABCB1—Metabolism—OXCT1—osteoporosis	8.49e-06	0.00102	CbGpPWpGaD
Toremifene—ESR1—Signaling Pathways—CNR2—osteoporosis	8.43e-06	0.00102	CbGpPWpGaD
Toremifene—ESR1—Signaling Pathways—NFATC1—osteoporosis	8.29e-06	0.001	CbGpPWpGaD
Toremifene—CYP1A1—Metabolism—CYP27A1—osteoporosis	8.28e-06	0.000999	CbGpPWpGaD
Toremifene—ABCB1—Metabolism—MGLL—osteoporosis	8.28e-06	0.000998	CbGpPWpGaD
Toremifene—ESR1—Signaling Pathways—DKK1—osteoporosis	8.23e-06	0.000992	CbGpPWpGaD
Toremifene—CYP1A1—Metabolism—ACP5—osteoporosis	8.06e-06	0.000972	CbGpPWpGaD
Toremifene—CYP1A2—Metabolism—ATIC—osteoporosis	7.97e-06	0.000961	CbGpPWpGaD
Toremifene—CYP1A2—Metabolism—PNP—osteoporosis	7.97e-06	0.000961	CbGpPWpGaD
Toremifene—CYP1A1—Metabolism of lipids and lipoproteins—GPX1—osteoporosis	7.96e-06	0.000959	CbGpPWpGaD
Toremifene—ESR1—Signaling Pathways—WNT1—osteoporosis	7.92e-06	0.000956	CbGpPWpGaD
Toremifene—ESR1—Signaling Pathways—FGA—osteoporosis	7.71e-06	0.00093	CbGpPWpGaD
Toremifene—CYP3A4—Biological oxidations—POMC—osteoporosis	7.53e-06	0.000907	CbGpPWpGaD
Toremifene—CYP1A1—Metabolism—TPI1—osteoporosis	7.49e-06	0.000903	CbGpPWpGaD
Toremifene—ESR1—Gene Expression—VDR—osteoporosis	7.38e-06	0.00089	CbGpPWpGaD
Toremifene—ESR1—Signaling Pathways—PTHLH—osteoporosis	7.17e-06	0.000864	CbGpPWpGaD
Toremifene—ESR1—Signaling Pathways—BMP2—osteoporosis	7.17e-06	0.000864	CbGpPWpGaD
Toremifene—CYP3A4—Metabolism—FDPS—osteoporosis	7.1e-06	0.000856	CbGpPWpGaD
Toremifene—CYP3A4—Metabolism—PKM—osteoporosis	7.1e-06	0.000856	CbGpPWpGaD
Toremifene—CYP1A1—Metabolism—P4HB—osteoporosis	7.04e-06	0.000849	CbGpPWpGaD
Toremifene—ABCB1—Metabolism—IDH2—osteoporosis	7.04e-06	0.000849	CbGpPWpGaD
Toremifene—ESR1—Signaling Pathways—FGB—osteoporosis	7.01e-06	0.000846	CbGpPWpGaD
Toremifene—CYP1A1—Metabolism—GAPDH—osteoporosis	6.91e-06	0.000834	CbGpPWpGaD
Toremifene—CYP1A2—Metabolism—CA2—osteoporosis	6.78e-06	0.000818	CbGpPWpGaD
Toremifene—CYP1A2—Metabolism—OXCT1—osteoporosis	6.78e-06	0.000818	CbGpPWpGaD
Toremifene—ESR1—Signaling Pathways—PSMA5—osteoporosis	6.77e-06	0.000816	CbGpPWpGaD
Toremifene—ESR1—Signaling Pathways—PSMA2—osteoporosis	6.77e-06	0.000816	CbGpPWpGaD
Toremifene—CYP1A1—Metabolism—RAP1A—osteoporosis	6.73e-06	0.000812	CbGpPWpGaD
Toremifene—CYP3A4—Metabolism—PGLS—osteoporosis	6.73e-06	0.000811	CbGpPWpGaD
Toremifene—CYP3A4—Metabolism—GPD2—osteoporosis	6.73e-06	0.000811	CbGpPWpGaD
Toremifene—ABCB1—Metabolism—CYP27A1—osteoporosis	6.62e-06	0.000798	CbGpPWpGaD
Toremifene—CYP1A2—Metabolism—MGLL—osteoporosis	6.61e-06	0.000797	CbGpPWpGaD
Toremifene—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—osteoporosis	6.49e-06	0.000783	CbGpPWpGaD
Toremifene—ABCB1—Integrated Pancreatic Cancer Pathway—TGFB1—osteoporosis	6.48e-06	0.000781	CbGpPWpGaD
Toremifene—ABCB1—Metabolism—ACP5—osteoporosis	6.44e-06	0.000776	CbGpPWpGaD
Toremifene—ESR1—Signaling Pathways—CALCA—osteoporosis	6.31e-06	0.000761	CbGpPWpGaD
Toremifene—CYP1A2—Metabolism of lipids and lipoproteins—CYP19A1—osteoporosis	6.23e-06	0.000751	CbGpPWpGaD
Toremifene—CYP3A4—Metabolism—ATIC—osteoporosis	6.15e-06	0.000742	CbGpPWpGaD
Toremifene—CYP3A4—Metabolism—PNP—osteoporosis	6.15e-06	0.000742	CbGpPWpGaD
Toremifene—ESR1—Generic Transcription Pathway—MYC—osteoporosis	6.1e-06	0.000735	CbGpPWpGaD
Toremifene—ABCB1—Transmembrane transport of small molecules—ADCY5—osteoporosis	6.06e-06	0.000731	CbGpPWpGaD
Toremifene—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—osteoporosis	6.05e-06	0.000729	CbGpPWpGaD
Toremifene—ABCB1—Metabolism—TPI1—osteoporosis	5.98e-06	0.000722	CbGpPWpGaD
Toremifene—CYP1A1—Metabolism of lipids and lipoproteins—POMC—osteoporosis	5.87e-06	0.000708	CbGpPWpGaD
Toremifene—ESR1—Signaling Pathways—KL—osteoporosis	5.73e-06	0.000691	CbGpPWpGaD
Toremifene—ABCB1—Metabolism—P4HB—osteoporosis	5.63e-06	0.000678	CbGpPWpGaD
Toremifene—CYP1A2—Metabolism—IDH2—osteoporosis	5.62e-06	0.000677	CbGpPWpGaD
Toremifene—ABCB1—Metabolism—GAPDH—osteoporosis	5.52e-06	0.000666	CbGpPWpGaD
Toremifene—CYP1A1—Metabolism—ENO1—osteoporosis	5.44e-06	0.000656	CbGpPWpGaD
Toremifene—ABCB1—Metabolism—RAP1A—osteoporosis	5.38e-06	0.000649	CbGpPWpGaD
Toremifene—CYP1A1—Metabolism—PSMA2—osteoporosis	5.36e-06	0.000647	CbGpPWpGaD
Toremifene—CYP1A1—Metabolism—PSMA5—osteoporosis	5.36e-06	0.000647	CbGpPWpGaD
Toremifene—CYP1A2—Metabolism—CYP27A1—osteoporosis	5.28e-06	0.000637	CbGpPWpGaD
Toremifene—CYP3A4—Metabolism—CA2—osteoporosis	5.23e-06	0.000631	CbGpPWpGaD
Toremifene—CYP3A4—Metabolism—OXCT1—osteoporosis	5.23e-06	0.000631	CbGpPWpGaD
Toremifene—CYP1A2—Metabolism—ACP5—osteoporosis	5.14e-06	0.00062	CbGpPWpGaD
Toremifene—CYP3A4—Metabolism—MGLL—osteoporosis	5.1e-06	0.000615	CbGpPWpGaD
Toremifene—CYP1A2—Metabolism of lipids and lipoproteins—GPX1—osteoporosis	5.07e-06	0.000612	CbGpPWpGaD
Toremifene—CYP1A2—Metabolism—TPI1—osteoporosis	4.78e-06	0.000576	CbGpPWpGaD
Toremifene—CYP1A2—Metabolism—P4HB—osteoporosis	4.49e-06	0.000542	CbGpPWpGaD
Toremifene—ESR1—Signaling Pathways—ADCY5—osteoporosis	4.49e-06	0.000541	CbGpPWpGaD
Toremifene—CYP1A2—Metabolism—GAPDH—osteoporosis	4.41e-06	0.000532	CbGpPWpGaD
Toremifene—CYP1A1—Metabolism—CYP19A1—osteoporosis	4.35e-06	0.000525	CbGpPWpGaD
Toremifene—ABCB1—Metabolism—ENO1—osteoporosis	4.35e-06	0.000524	CbGpPWpGaD
Toremifene—ESR1—Signaling Pathways—SPP1—osteoporosis	4.34e-06	0.000524	CbGpPWpGaD
Toremifene—CYP3A4—Metabolism—IDH2—osteoporosis	4.34e-06	0.000523	CbGpPWpGaD
Toremifene—CYP1A2—Metabolism—RAP1A—osteoporosis	4.29e-06	0.000518	CbGpPWpGaD
Toremifene—ABCB1—Metabolism—PSMA5—osteoporosis	4.28e-06	0.000517	CbGpPWpGaD
Toremifene—ABCB1—Metabolism—PSMA2—osteoporosis	4.28e-06	0.000517	CbGpPWpGaD
Toremifene—CYP3A4—Metabolism—CYP27A1—osteoporosis	4.08e-06	0.000492	CbGpPWpGaD
Toremifene—CYP3A4—Metabolism—ACP5—osteoporosis	3.97e-06	0.000478	CbGpPWpGaD
Toremifene—ESR1—Signaling Pathways—IRS2—osteoporosis	3.93e-06	0.000474	CbGpPWpGaD
Toremifene—ESR1—Signaling Pathways—LEP—osteoporosis	3.84e-06	0.000463	CbGpPWpGaD
Toremifene—CYP1A2—Metabolism of lipids and lipoproteins—POMC—osteoporosis	3.74e-06	0.000452	CbGpPWpGaD
Toremifene—CYP3A4—Metabolism—TPI1—osteoporosis	3.69e-06	0.000445	CbGpPWpGaD
Toremifene—CYP1A1—Metabolism—ADCY5—osteoporosis	3.56e-06	0.000429	CbGpPWpGaD
Toremifene—CYP1A1—Metabolism—GPX1—osteoporosis	3.54e-06	0.000427	CbGpPWpGaD
Toremifene—ABCB1—Metabolism—CYP19A1—osteoporosis	3.48e-06	0.000419	CbGpPWpGaD
Toremifene—CYP1A2—Metabolism—ENO1—osteoporosis	3.47e-06	0.000419	CbGpPWpGaD
Toremifene—CYP3A4—Metabolism—P4HB—osteoporosis	3.47e-06	0.000418	CbGpPWpGaD
Toremifene—ESR1—Signaling Pathways—IRS1—osteoporosis	3.43e-06	0.000413	CbGpPWpGaD
Toremifene—CYP1A2—Metabolism—PSMA2—osteoporosis	3.42e-06	0.000412	CbGpPWpGaD
Toremifene—CYP1A2—Metabolism—PSMA5—osteoporosis	3.42e-06	0.000412	CbGpPWpGaD
Toremifene—CYP3A4—Metabolism—GAPDH—osteoporosis	3.4e-06	0.00041	CbGpPWpGaD
Toremifene—CYP3A4—Metabolism—RAP1A—osteoporosis	3.31e-06	0.0004	CbGpPWpGaD
Toremifene—ESR1—Signaling Pathways—POMC—osteoporosis	3.3e-06	0.000398	CbGpPWpGaD
Toremifene—CYP1A1—Metabolism—MTHFR—osteoporosis	3.27e-06	0.000394	CbGpPWpGaD
Toremifene—ESR1—Signaling Pathways—IL6R—osteoporosis	3.22e-06	0.000388	CbGpPWpGaD
Toremifene—ESR1—Signaling Pathways—IGF1—osteoporosis	3.18e-06	0.000383	CbGpPWpGaD
Toremifene—ESR1—Gene Expression—MYC—osteoporosis	2.94e-06	0.000354	CbGpPWpGaD
Toremifene—ABCB1—Metabolism—ADCY5—osteoporosis	2.84e-06	0.000342	CbGpPWpGaD
Toremifene—ABCB1—Metabolism—GPX1—osteoporosis	2.83e-06	0.000341	CbGpPWpGaD
Toremifene—CYP1A2—Metabolism—CYP19A1—osteoporosis	2.77e-06	0.000335	CbGpPWpGaD
Toremifene—CYP3A4—Metabolism—ENO1—osteoporosis	2.68e-06	0.000323	CbGpPWpGaD
Toremifene—CYP3A4—Metabolism—PSMA2—osteoporosis	2.64e-06	0.000318	CbGpPWpGaD
Toremifene—CYP3A4—Metabolism—PSMA5—osteoporosis	2.64e-06	0.000318	CbGpPWpGaD
Toremifene—CYP1A1—Metabolism—POMC—osteoporosis	2.62e-06	0.000315	CbGpPWpGaD
Toremifene—ABCB1—Metabolism—MTHFR—osteoporosis	2.61e-06	0.000315	CbGpPWpGaD
Toremifene—CYP1A2—Metabolism—ADCY5—osteoporosis	2.27e-06	0.000273	CbGpPWpGaD
Toremifene—CYP1A2—Metabolism—GPX1—osteoporosis	2.26e-06	0.000272	CbGpPWpGaD
Toremifene—CYP3A4—Metabolism—CYP19A1—osteoporosis	2.14e-06	0.000258	CbGpPWpGaD
Toremifene—ABCB1—Metabolism—POMC—osteoporosis	2.09e-06	0.000252	CbGpPWpGaD
Toremifene—CYP1A2—Metabolism—MTHFR—osteoporosis	2.09e-06	0.000251	CbGpPWpGaD
Toremifene—ESR1—Signaling Pathways—MYC—osteoporosis	1.91e-06	0.00023	CbGpPWpGaD
Toremifene—ESR1—Signaling Pathways—TGFB1—osteoporosis	1.9e-06	0.00023	CbGpPWpGaD
Toremifene—CYP3A4—Metabolism—ADCY5—osteoporosis	1.75e-06	0.000211	CbGpPWpGaD
Toremifene—CYP3A4—Metabolism—GPX1—osteoporosis	1.74e-06	0.00021	CbGpPWpGaD
Toremifene—CYP1A2—Metabolism—POMC—osteoporosis	1.67e-06	0.000201	CbGpPWpGaD
Toremifene—CYP3A4—Metabolism—MTHFR—osteoporosis	1.61e-06	0.000194	CbGpPWpGaD
Toremifene—ESR1—Signaling Pathways—IL6—osteoporosis	1.43e-06	0.000173	CbGpPWpGaD
Toremifene—CYP3A4—Metabolism—POMC—osteoporosis	1.29e-06	0.000155	CbGpPWpGaD
